Connable Office’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Connable Office's AZN Position: Q3 2026 in Review
Connable Office reduced its AstraZeneca (AZN) stake by 47% in Q3 2026, selling an estimated $454K and leaving 3,123 shares worth $504K. The position accounts for 0.04% of the portfolio, ranked #138.
Connable Office first reported a position in AZN in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.7M in Q2 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Connable Office held 3,123 shares of AstraZeneca worth $504K as of Q3 2026.
- Connable Office sold 2,725 AstraZeneca shares in Q3 2026, an estimated $454K.
- AstraZeneca made up 0.04% of Connable Office's portfolio in Q3 2026, its #138 holding.
- Connable Office first reported a position in AstraZeneca in Q2 2013 and has held it in 21 quarters since.
- Connable Office's AstraZeneca position peaked at $1.7M in Q2 2024.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.